New combo therapy aims to prevent dangerous pregnancy condition
NCT ID NCT07361679
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a blood thinner (low molecular weight heparin) to daily low-dose aspirin can prevent preeclampsia in pregnant women at high risk. Preeclampsia is a serious condition causing high blood pressure and organ damage. The trial will enroll 100 women early in pregnancy and compare the two treatments to see which works better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Department of Obstetrics and Gynecology, Alexandra Hospital
RECRUITINGAthens, Attica, 11528, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple tape measure make blood pressure readings more accurate in pregnancy?
- Can a climate-smart pregnancy care program prevent stillbirths in a fast-growing city?
- Could a placental protein unlock the mystery of preeclampsia?
- Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
- Text messages and personal support may reduce pregnancy risks — a trial puts them to the test
- Ultrasound may predict hidden placental problems before delivery